Developing and marketing innovative vaccines and therapeutics
Emergent Biosolutions is a global specialty biopharmaceutical company developing and marketing innovative vaccines and therapeutics for certain infectious diseases, oncology and autoimmunity
Advent invested in Microscience in 2001. Microscience was acquired by Emergent in 2005. Emergent listed on NYSE in November 2006 (NYSE:EBS).